As of close of business last night, Unitedhealth Group Inc’s stock clocked out at $473.15, down -1.81% from its previous closing price of $481.87. In other words, the price has decreased by -$8.72 from its previous closing price. On the day, 5185839 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
To gain a deeper understanding of UNH’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.70.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, HSBC Securities on December 18, 2023, Downgraded its rating to Reduce and sets its target price to $480 from $550 previously.
On October 16, 2023, UBS Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $520 to $640.
On September 06, 2023, HSBC Securities started tracking the stock assigning a Hold rating and target price of $540.HSBC Securities initiated its Hold rating on September 06, 2023, with a $540 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 23 when ROOS THOMAS E sold 858 shares for $525.79 per share. The transaction valued at 451,128 led to the insider holds 32,289 shares of the business.
THOMPSON BRIAN R sold 28,943 shares of UNH for $15,079,303 on Feb 16. The CEO, UnitedHealthcare now owns 25,543 shares after completing the transaction at $521.00 per share. On Dec 05, another insider, HEMSLEY STEPHEN J, who serves as the Director of the company, sold 66,081 shares for $550.39 each. As a result, the insider received 36,370,196 and left with 635,528 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 436.21B and an Enterprise Value of 469.12B. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.84, and their Forward P/E ratio for the next fiscal year is 15.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.17 while its Price-to-Book (P/B) ratio in mrq is 4.93. Its current Enterprise Value per Revenue stands at 1.26 whereas that against EBITDA is 12.91.
Stock Price History:
Over the past 52 weeks, UNH has reached a high of $554.70, while it has fallen to a 52-week low of $445.68. The 50-Day Moving Average of the stock is 517.84, while the 200-Day Moving Average is calculated to be 508.83.
Shares Statistics:
It appears that UNH traded 3.86M shares on average per day over the past three months and 4.54M shares per day over the past ten days. A total of 924.00M shares are outstanding, with a floating share count of 920.26M. Insiders hold about 0.18% of the company’s shares, while institutions hold 90.46% stake in the company. Shares short for UNH as of Feb 15, 2024 were 6.34M with a Short Ratio of 1.64, compared to 6.26M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.69% and a Short% of Float of 0.69%.
Dividends & Splits
With its trailing 12-month dividend rate of 7.29, UNH has a forward annual dividend rate of 7.29. Against a Trailing Annual Dividend Yield of 1.51%, it implies a Forward Annual Dividend Yield of 1.56%. The stock’s 5-year Average Dividend Yield is 1.37. The current Payout Ratio is 30.55% for UNH, which recently paid a dividend on Mar 19, 2024 with an ex-dividend date of Mar 08, 2024. Stock splits for the company last occurred on May 31, 2005 when the company split stock in a 2:1 ratio.
Earnings Estimates
As of right now, 20 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of $6.68 for the current quarter, with a high estimate of $7.06 and a low estimate of $4.58, while EPS last year was $5.72. The consensus estimate for the next quarter is $6.91, with high estimates of $7.06 and low estimates of $6.43.
Analysts are recommending an EPS of between $28.18 and $27.03 for the fiscal current year, implying an average EPS of $27.8. EPS for the following year is $31.35, with 23 analysts recommending between $31.85 and $30.39.
Revenue Estimates
In the current quarter, 16 analysts expect revenue to total $99.47B. It ranges from a high estimate of $101B to a low estimate of $96.4B. As of the current estimate, Unitedhealth Group Inc’s year-ago sales were $89.78B, an estimated increase of 10.80% from the year-ago figure.
A total of 20 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $404.15B, while the lowest revenue estimate was $395.42B, resulting in an average revenue estimate of $401.05B. In the same quarter a year ago, actual revenue was $371.62B, up 7.90% from the average estimate. Based on 20 analysts’ estimates, the company’s revenue will be $432.09B in the next fiscal year. The high estimate is $438.52B and the low estimate is $414.1B. The average revenue growth estimate for next year is up 7.70% from the average revenue estimate for this year.
